INS and type 2 diabetes mellitus: A total of 39 T2DM patients (21.7%) were on insulin therapy (Fig. 1), with a mean duration of 32.4 ± 36.6 months; of them, 28 (75.7%) patients started insulin therapy for at least three months before the study’s initiation.